136 related articles for article (PubMed ID: 19168871)
1. Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability.
Rodewald M; Herr D; Duncan WC; Fraser HM; Hack G; Konrad R; Gagsteiger F; Kreienberg R; Wulff C
Hum Reprod; 2009 May; 24(5):1191-9. PubMed ID: 19168871
[TBL] [Abstract][Full Text] [Related]
2. Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.
Bishop CV; Lee DM; Slayden OD; Li X
J Ovarian Res; 2017 Jul; 10(1):41. PubMed ID: 28683759
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial cadherin regulates vascular permeability: Implications for ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Ruiz A; Pellicer A; Garcia-Velasco JA
J Clin Endocrinol Metab; 2007 Jan; 92(1):314-21. PubMed ID: 17032719
[TBL] [Abstract][Full Text] [Related]
4. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome.
Albert C; Garrido N; Mercader A; Rao CV; Remohí J; Simón C; Pellicer A
Mol Hum Reprod; 2002 May; 8(5):409-18. PubMed ID: 11994537
[TBL] [Abstract][Full Text] [Related]
5. Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5.
Kitajima Y; Endo T; Nagasawa K; Manase K; Honnma H; Baba T; Hayashi T; Chiba H; Sawada N; Saito T
Endocrinology; 2006 Feb; 147(2):694-9. PubMed ID: 16269461
[TBL] [Abstract][Full Text] [Related]
6. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B; Aboulghar M; Smitz J; Ron-El R
Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
[TBL] [Abstract][Full Text] [Related]
7. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
[TBL] [Abstract][Full Text] [Related]
8. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
[TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
[TBL] [Abstract][Full Text] [Related]
10. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
[TBL] [Abstract][Full Text] [Related]
11. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
[TBL] [Abstract][Full Text] [Related]
12. Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability.
Bekes I; Haunerdinger V; Sauter R; Holzheu I; Janni W; Wöckel A; Wulff C
Geburtshilfe Frauenheilkd; 2017 Jan; 77(1):73-80. PubMed ID: 28190892
[No Abstract] [Full Text] [Related]
13. Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome.
Scotti L; Abramovich D; Pascuali N; Irusta G; Meresman G; Tesone M; Parborell F
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():392-401. PubMed ID: 25151950
[TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins.
Herr D; Fraser HM; Konrad R; Holzheu I; Kreienberg R; Wulff C
Fertil Steril; 2013 May; 99(6):1749-58. PubMed ID: 23465821
[TBL] [Abstract][Full Text] [Related]
15. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.
Soares SR; Gómez R; Simón C; García-Velasco JA; Pellicer A
Hum Reprod Update; 2008; 14(4):321-33. PubMed ID: 18385260
[TBL] [Abstract][Full Text] [Related]
16. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome.
Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F
Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469
[TBL] [Abstract][Full Text] [Related]
17. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
Gómez R; Lima I; Simón C; Pellicer A
Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
[TBL] [Abstract][Full Text] [Related]
18. New insights in mechanisms for development of ovarian hyperstimulation syndrome.
Kasum M
Coll Antropol; 2010 Sep; 34(3):1139-43. PubMed ID: 20977119
[TBL] [Abstract][Full Text] [Related]
19.
Zhang J; Huang J; He X; Li N; Miao Y; Li B; Shao X; Wang N
Gynecol Endocrinol; 2022 Feb; 38(2):170-175. PubMed ID: 34964405
[TBL] [Abstract][Full Text] [Related]
20. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]